Logo image of HAVAS.AS

HAVAS NV (HAVAS.AS) Stock Fundamental Analysis

AMS:HAVAS - Euronext Amsterdam - NL0015002AH0 - Common Stock - Currency: EUR

1.45  +0.01 (+0.5%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to HAVAS. HAVAS was compared to 57 industry peers in the Media industry. HAVAS has a bad profitability rating. Also its financial health evaluation is rather negative. HAVAS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

HAVAS had positive earnings in the past year.
HAVAS.AS Yearly Net Income VS EBIT VS OCF VS FCFHAVAS.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 100M 200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.56%, HAVAS is in line with its industry, outperforming 52.63% of the companies in the same industry.
Looking at the Return On Equity, with a value of 8.99%, HAVAS is in line with its industry, outperforming 57.89% of the companies in the same industry.
With a decent Return On Invested Capital value of 8.34%, HAVAS is doing good in the industry, outperforming 68.42% of the companies in the same industry.
Industry RankSector Rank
ROA 2.56%
ROE 8.99%
ROIC 8.34%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HAVAS.AS Yearly ROA, ROE, ROICHAVAS.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2 4 6 8

1.3 Margins

The Profit Margin of HAVAS (6.04%) is better than 63.16% of its industry peers.
The Operating Margin of HAVAS (11.84%) is better than 75.44% of its industry peers.
Industry RankSector Rank
OM 11.84%
PM (TTM) 6.04%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HAVAS.AS Yearly Profit, Operating, Gross MarginsHAVAS.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2 4 6 8 10

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), HAVAS is creating some value.
HAVAS has about the same amout of shares outstanding than it did 1 year ago.
HAVAS has a better debt/assets ratio than last year.
HAVAS.AS Yearly Shares OutstandingHAVAS.AS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 200M 400M 600M 800M
HAVAS.AS Yearly Total Debt VS Total AssetsHAVAS.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

HAVAS has an Altman-Z score of 0.75. This is a bad value and indicates that HAVAS is not financially healthy and even has some risk of bankruptcy.
HAVAS has a worse Altman-Z score (0.75) than 70.18% of its industry peers.
A Debt/Equity ratio of 0.30 indicates that HAVAS is not too dependend on debt financing.
HAVAS has a Debt to Equity ratio of 0.30. This is in the better half of the industry: HAVAS outperforms 64.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 0.75
ROIC/WACC1.22
WACC6.84%
HAVAS.AS Yearly LT Debt VS Equity VS FCFHAVAS.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 0.86 indicates that HAVAS may have some problems paying its short term obligations.
With a Current ratio value of 0.86, HAVAS is not doing good in the industry: 61.40% of the companies in the same industry are doing better.
A Quick Ratio of 0.83 indicates that HAVAS may have some problems paying its short term obligations.
HAVAS has a Quick ratio of 0.83. This is comparable to the rest of the industry: HAVAS outperforms 43.86% of its industry peers.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.83
HAVAS.AS Yearly Current Assets VS Current LiabilitesHAVAS.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

1

3. Growth

3.1 Past

HAVAS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -55.28%.
HAVAS shows a decrease in Revenue. In the last year, the revenue decreased by -0.31%.
EPS 1Y (TTM)-55.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-0.31%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 8.13% on average over the next years. This is quite good.
HAVAS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.04% yearly.
EPS Next Y9.51%
EPS Next 2Y8.94%
EPS Next 3Y8.13%
EPS Next 5YN/A
Revenue Next Year3.41%
Revenue Next 2Y3.04%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

HAVAS.AS Yearly Revenue VS EstimatesHAVAS.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 1B 2B 3B
HAVAS.AS Yearly EPS VS EstimatesHAVAS.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.05 0.1 0.15 0.2

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 8.53 indicates a reasonable valuation of HAVAS.
Compared to the rest of the industry, the Price/Earnings ratio of HAVAS indicates a somewhat cheap valuation: HAVAS is cheaper than 78.95% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 28.79. HAVAS is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 6.84, which indicates a rather cheap valuation of HAVAS.
Based on the Price/Forward Earnings ratio, HAVAS is valued cheaper than 89.47% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.38. HAVAS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.53
Fwd PE 6.84
HAVAS.AS Price Earnings VS Forward Price EarningsHAVAS.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

HAVAS's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. HAVAS is cheaper than 70.18% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.92
HAVAS.AS Per share dataHAVAS.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.9
PEG (5Y)N/A
EPS Next 2Y8.94%
EPS Next 3Y8.13%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HAVAS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HAVAS NV

AMS:HAVAS (4/25/2025, 7:00:00 PM)

1.45

+0.01 (+0.5%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)03-05 2025-03-05
Earnings (Next)04-30 2025-04-30
Inst Owners15.6%
Inst Owner ChangeN/A
Ins Owners2.67%
Ins Owner ChangeN/A
Market Cap1.44B
Analysts80
Price Target1.83 (26.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.01%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.53
Fwd PE 6.84
P/S 0.5
P/FCF N/A
P/OCF N/A
P/B 0.75
P/tB N/A
EV/EBITDA 3.92
EPS(TTM)0.17
EY11.72%
EPS(NY)0.21
Fwd EY14.62%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.89
BVpS1.94
TBVpS-0.66
PEG (NY)0.9
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.56%
ROE 8.99%
ROCE 12.91%
ROIC 8.34%
ROICexc 9.14%
ROICexgc N/A
OM 11.84%
PM (TTM) 6.04%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA 1.31
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.86
Quick Ratio 0.83
Altman-Z 0.75
F-ScoreN/A
WACC6.84%
ROIC/WACC1.22
Cap/Depr(3y)29.4%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.25%
Cap/Sales(5y)N/A
Profit Quality(3y)168.96%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-55.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y9.51%
EPS Next 2Y8.94%
EPS Next 3Y8.13%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.31%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year3.41%
Revenue Next 2Y3.04%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y7.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year43.98%
EBIT Next 3Y16.33%
EBIT Next 5YN/A
FCF growth 1Y-27.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.63%
OCF growth 3YN/A
OCF growth 5YN/A